This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second Look: Discussing the FDA approved label update for Biktarvy to include pregnant adults with HIV based on the additional data from Study 5310.

Ticker(s): GILD

Who's the expert?

Institution: Penn State Health

  • Professor of Obstetrics and Gynecology, and Radiology at Penn State Health.
  • Manages 75 patients per month with urinary tract infections and Treats 25 pregnant adults with HIV
  • Serves as the director of Perinatal Ultrasonography and Maternal Fetal Medicine Fellowship Training Program.

Interview Goal
,

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.